Glenmark Pharma shares falls 2% after subsidiary stake sale

According to a regulatory filing, Glenmark Pharmaceuticals has entered into a definitive agreement with Nirma to divest 75 percent stake in Glenmark Life Sciences for Rs 5,651.5 crore, at a price of Rs 615 per share.

Related Keywords

Sekhmet Pharmaventures , Glenmark Pharma , Glen Saldanha , Motilal Oswal , Glenmark Lifesciences , Glenmark Life Sciences For Rs , Glenmark Life Sciences , Glenmark Life Sciences To Nirma , Glenmark Pharmaceuticals , Glenmark Life , Irma ,